Market Tracker

12/05 4:38pm ET

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

1.50
Delayed Data
As of Dec 05
 0.00 / 0.00%
Today’s Change
1.33
Today|||52-Week Range
5.19
-67.67%
Year-to-Date
No recent news for Anthera Pharmaceuticals Inc.

Today’s Trading

Previous close1.50
Today’s open1.40
Day’s range1.40 - 1.55
Volume613,290
Average volume (3 months)563,065
Market cap$62.9M
Dividend yield--
Data as of 3:59pm ET, 12/05/2016

Growth & Valuation

Earnings growth (last year)+27.21%
Earnings growth (this year)-55.65%
Earnings growth (next 5 years)+78.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales51.91
Price/Book1.51

Competitors

 Today’s
change
Today’s
% change
DRNADicerna Pharmaceutic...+0.03+0.99%
LPCNLipocine Inc+0.25+7.35%
STDYSteadymed Ltd+0.10+3.23%
PTNPalatin Technologies...-0.00-0.03%
Data as of 4:01pm ET, 12/05/2016

Financials

Next reporting dateMarch 28, 2017
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$3.2M
Annual profit (last year)-$35.2M
Net profit margin-1,105.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Paul F. Truex
President &
Chief Operating Officer
John Craig Thompson
Corporate headquarters
Hayward, California

Forecasts